Cardiovascular Protective Effects of n-3 Polyunsaturated Fatty Acids With Special Emphasis on Docosahexaenoic Acid
It is widely accepted that n-3 polyunsaturated fatty acids (PUFAs) rich in fish oils protect against several types of cardiovascular diseases such as myocardial infarction, arrhythmia, atherosclerosis, or hypertension. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) may be the active biol...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2003-01-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319326295 |
_version_ | 1819011683067101184 |
---|---|
author | Masahiko Hirafuji Takuji Machida Naoya Hamaue Masaru Minami |
author_facet | Masahiko Hirafuji Takuji Machida Naoya Hamaue Masaru Minami |
author_sort | Masahiko Hirafuji |
collection | DOAJ |
description | It is widely accepted that n-3 polyunsaturated fatty acids (PUFAs) rich in fish oils protect against several types of cardiovascular diseases such as myocardial infarction, arrhythmia, atherosclerosis, or hypertension. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) may be the active biological components of these effects. Although the precise cellular and molecular mechanisms underlying the beneficial effects are still uncertain, the protective effects of n-3 PUFAs are attributable to their direct effects on vascular smooth muscle cell (VSMC) functions. These n-3 PUFAs activate K+ATP channels and inhibit certain types of Ca2+ channels, probably via at least 2 distinct mechanisms. N-3 PUFAs favorably alter the eicosanoid profile and regulate cytokine-induced expression of inducible nitric oxide synthase and cyclooxygenase-2 via mechanisms involving modulation of signaling transduction events. N-3 PUFAs also modulate VSMC proliferation, migration, and apoptosis. These recent data suggest that modulation of these VSMC functions contribute to the beneficial effects of n-3 PUFAs on various cardiovascular disorders. Furthermore, recent studies strongly suggest that DHA has more potent and beneficial effects than EPA. However, many questions about the cellular and molecular mechanisms still remain to be answered. |
first_indexed | 2024-12-21T01:32:03Z |
format | Article |
id | doaj.art-c20ff015ed5e415da2f8677bf1aeca69 |
institution | Directory Open Access Journal |
issn | 1347-8613 |
language | English |
last_indexed | 2024-12-21T01:32:03Z |
publishDate | 2003-01-01 |
publisher | Elsevier |
record_format | Article |
series | Journal of Pharmacological Sciences |
spelling | doaj.art-c20ff015ed5e415da2f8677bf1aeca692022-12-21T19:20:21ZengElsevierJournal of Pharmacological Sciences1347-86132003-01-01924308316Cardiovascular Protective Effects of n-3 Polyunsaturated Fatty Acids With Special Emphasis on Docosahexaenoic AcidMasahiko Hirafuji0Takuji Machida1Naoya Hamaue2Masaru Minami3Department of Pharmacology, Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Hokkaido 061-0293, JapanDepartment of Pharmacology, Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Hokkaido 061-0293, JapanDepartment of Pharmacology, Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Hokkaido 061-0293, JapanDepartment of Pharmacology, Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Hokkaido 061-0293, JapanIt is widely accepted that n-3 polyunsaturated fatty acids (PUFAs) rich in fish oils protect against several types of cardiovascular diseases such as myocardial infarction, arrhythmia, atherosclerosis, or hypertension. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) may be the active biological components of these effects. Although the precise cellular and molecular mechanisms underlying the beneficial effects are still uncertain, the protective effects of n-3 PUFAs are attributable to their direct effects on vascular smooth muscle cell (VSMC) functions. These n-3 PUFAs activate K+ATP channels and inhibit certain types of Ca2+ channels, probably via at least 2 distinct mechanisms. N-3 PUFAs favorably alter the eicosanoid profile and regulate cytokine-induced expression of inducible nitric oxide synthase and cyclooxygenase-2 via mechanisms involving modulation of signaling transduction events. N-3 PUFAs also modulate VSMC proliferation, migration, and apoptosis. These recent data suggest that modulation of these VSMC functions contribute to the beneficial effects of n-3 PUFAs on various cardiovascular disorders. Furthermore, recent studies strongly suggest that DHA has more potent and beneficial effects than EPA. However, many questions about the cellular and molecular mechanisms still remain to be answered.http://www.sciencedirect.com/science/article/pii/S1347861319326295 |
spellingShingle | Masahiko Hirafuji Takuji Machida Naoya Hamaue Masaru Minami Cardiovascular Protective Effects of n-3 Polyunsaturated Fatty Acids With Special Emphasis on Docosahexaenoic Acid Journal of Pharmacological Sciences |
title | Cardiovascular Protective Effects of n-3 Polyunsaturated Fatty Acids With Special Emphasis on Docosahexaenoic Acid |
title_full | Cardiovascular Protective Effects of n-3 Polyunsaturated Fatty Acids With Special Emphasis on Docosahexaenoic Acid |
title_fullStr | Cardiovascular Protective Effects of n-3 Polyunsaturated Fatty Acids With Special Emphasis on Docosahexaenoic Acid |
title_full_unstemmed | Cardiovascular Protective Effects of n-3 Polyunsaturated Fatty Acids With Special Emphasis on Docosahexaenoic Acid |
title_short | Cardiovascular Protective Effects of n-3 Polyunsaturated Fatty Acids With Special Emphasis on Docosahexaenoic Acid |
title_sort | cardiovascular protective effects of n 3 polyunsaturated fatty acids with special emphasis on docosahexaenoic acid |
url | http://www.sciencedirect.com/science/article/pii/S1347861319326295 |
work_keys_str_mv | AT masahikohirafuji cardiovascularprotectiveeffectsofn3polyunsaturatedfattyacidswithspecialemphasisondocosahexaenoicacid AT takujimachida cardiovascularprotectiveeffectsofn3polyunsaturatedfattyacidswithspecialemphasisondocosahexaenoicacid AT naoyahamaue cardiovascularprotectiveeffectsofn3polyunsaturatedfattyacidswithspecialemphasisondocosahexaenoicacid AT masaruminami cardiovascularprotectiveeffectsofn3polyunsaturatedfattyacidswithspecialemphasisondocosahexaenoicacid |